Tianshui Zhongxing Bio-technology Co Ltd (002772) - Net Assets
Based on the latest financial reports, Tianshui Zhongxing Bio-technology Co Ltd (002772) has net assets worth CN¥3.56 Billion CNY (≈ $521.45 Million USD) as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥7.74 Billion ≈ $1.13 Billion USD) and total liabilities (CN¥4.18 Billion ≈ $611.51 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Tianshui Zhongxing Bio-technology Co Ltd PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥3.56 Billion |
| % of Total Assets | 46.03% |
| Annual Growth Rate | 23.92% |
| 5-Year Change | 12.42% |
| 10-Year Change | 59.44% |
| Growth Volatility | 41.86 |
Tianshui Zhongxing Bio-technology Co Ltd - Net Assets Trend (2011–2025)
This chart illustrates how Tianshui Zhongxing Bio-technology Co Ltd's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see 002772 market cap overview.
Annual Net Assets for Tianshui Zhongxing Bio-technology Co Ltd (2011–2025)
The table below shows the annual net assets of Tianshui Zhongxing Bio-technology Co Ltd from 2011 to 2025. Also explore net asset growth rate of Tianshui Zhongxing Bio-technology Co Ltd to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥3.66 Billion ≈ $534.85 Million |
+10.13% |
| 2024-12-31 | CN¥3.32 Billion ≈ $485.64 Million |
-3.40% |
| 2023-12-31 | CN¥3.44 Billion ≈ $502.73 Million |
+1.50% |
| 2022-12-31 | CN¥3.38 Billion ≈ $495.28 Million |
+4.11% |
| 2021-12-31 | CN¥3.25 Billion ≈ $475.74 Million |
+18.99% |
| 2020-12-31 | CN¥2.73 Billion ≈ $399.82 Million |
+5.00% |
| 2019-12-31 | CN¥2.60 Billion ≈ $380.77 Million |
-1.16% |
| 2018-12-31 | CN¥2.63 Billion ≈ $385.22 Million |
-0.08% |
| 2017-12-31 | CN¥2.63 Billion ≈ $385.54 Million |
+14.93% |
| 2016-12-31 | CN¥2.29 Billion ≈ $335.46 Million |
+120.87% |
| 2015-12-31 | CN¥1.04 Billion ≈ $151.88 Million |
+108.40% |
| 2014-12-31 | CN¥498.05 Million ≈ $72.88 Million |
+22.30% |
| 2013-12-31 | CN¥407.25 Million ≈ $59.59 Million |
+15.93% |
| 2012-12-31 | CN¥351.30 Million ≈ $51.41 Million |
+93.56% |
| 2011-12-31 | CN¥181.49 Million ≈ $26.56 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Tianshui Zhongxing Bio-technology Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 3313.5% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥1.16 Billion | 32.93% |
| Common Stock | CN¥393.24 Million | 11.15% |
| Other Comprehensive Income | CN¥94.25 Million | 2.67% |
| Other Components | CN¥1.88 Billion | 53.25% |
| Total Equity | CN¥3.53 Billion | 100.00% |
Tianshui Zhongxing Bio-technology Co Ltd Competitors by Market Cap
The table below lists competitors of Tianshui Zhongxing Bio-technology Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Anhui Province Natural Gas Development Co Ltd
SHG:603689
|
$583.47 Million |
|
Cars.com Inc
NYSE:CARS
|
$583.51 Million |
|
Puyang Refractories Group Co Ltd
SHE:002225
|
$583.54 Million |
|
Hapvida Participações e Investimentos S.A.
SA:HAPV3
|
$583.56 Million |
|
Adcock Ingram Holdings Limited
JSE:AIP
|
$583.42 Million |
|
Lotus Technology Inc.
NASDAQ:LOT
|
$583.32 Million |
|
Integral Diagnostics Ltd
AU:IDX
|
$583.15 Million |
|
Ricegrowers Ltd
AU:SGLLV
|
$582.74 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Tianshui Zhongxing Bio-technology Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 3,317,126,129 to 3,525,793,207, a change of 208,667,078 (6.3%).
- Net income of 334,963,547 contributed positively to equity growth.
- Dividend payments of 112,422,759 reduced retained earnings.
- Share repurchases of 21,963,255 reduced equity.
- Other comprehensive income increased equity by 23,093,689.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥334.96 Million | +9.5% |
| Dividends Paid | CN¥112.42 Million | -3.19% |
| Share Repurchases | CN¥21.96 Million | -0.62% |
| Other Comprehensive Income | CN¥23.09 Million | +0.65% |
| Other Changes | CN¥-15.00 Million | -0.43% |
| Total Change | CN¥- | 6.29% |
Book Value vs Market Value Analysis
This analysis compares Tianshui Zhongxing Bio-technology Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.13x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 13.04x to 1.13x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2011-12-31 | CN¥0.82 | CN¥10.64 | x |
| 2012-12-31 | CN¥1.57 | CN¥10.64 | x |
| 2013-12-31 | CN¥1.77 | CN¥10.64 | x |
| 2014-12-31 | CN¥2.15 | CN¥10.64 | x |
| 2015-12-31 | CN¥3.66 | CN¥10.64 | x |
| 2016-12-31 | CN¥6.77 | CN¥10.64 | x |
| 2017-12-31 | CN¥7.01 | CN¥10.64 | x |
| 2018-12-31 | CN¥7.05 | CN¥10.64 | x |
| 2019-12-31 | CN¥7.22 | CN¥10.64 | x |
| 2020-12-31 | CN¥8.09 | CN¥10.64 | x |
| 2021-12-31 | CN¥8.27 | CN¥10.64 | x |
| 2022-12-31 | CN¥8.54 | CN¥10.64 | x |
| 2023-12-31 | CN¥8.42 | CN¥10.64 | x |
| 2024-12-31 | CN¥8.47 | CN¥10.64 | x |
| 2025-12-31 | CN¥9.38 | CN¥10.64 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Tianshui Zhongxing Bio-technology Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 9.50%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 15.96%
- • Asset Turnover: 0.30x
- • Equity Multiplier: 2.01x
- Recent ROE (9.50%) is above the historical average (9.05%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2011 | 24.01% | 33.18% | 0.44x | 1.63x | CN¥25.43 Million |
| 2012 | 18.28% | 33.61% | 0.34x | 1.60x | CN¥28.99 Million |
| 2013 | 13.53% | 20.74% | 0.33x | 1.97x | CN¥14.27 Million |
| 2014 | 18.33% | 23.70% | 0.36x | 2.14x | CN¥41.31 Million |
| 2015 | 11.09% | 23.85% | 0.28x | 1.63x | CN¥11.25 Million |
| 2016 | 6.94% | 27.09% | 0.18x | 1.41x | CN¥-69.79 Million |
| 2017 | 5.42% | 19.23% | 0.18x | 1.56x | CN¥-120.20 Million |
| 2018 | 4.26% | 12.08% | 0.23x | 1.56x | CN¥-151.11 Million |
| 2019 | 2.63% | 5.92% | 0.23x | 1.93x | CN¥-191.54 Million |
| 2020 | 6.92% | 12.74% | 0.27x | 2.05x | CN¥-83.95 Million |
| 2021 | 1.69% | 3.53% | 0.24x | 2.02x | CN¥-269.89 Million |
| 2022 | 4.68% | 8.04% | 0.30x | 1.94x | CN¥-179.81 Million |
| 2023 | 4.65% | 8.26% | 0.32x | 1.77x | CN¥-183.67 Million |
| 2024 | 3.86% | 6.62% | 0.31x | 1.87x | CN¥-203.68 Million |
| 2025 | 9.50% | 15.96% | 0.30x | 2.01x | CN¥-17.62 Million |
Industry Comparison
This section compares Tianshui Zhongxing Bio-technology Co Ltd's net assets metrics with peer companies in the Farm Products industry.
Industry Context
- Industry: Farm Products
- Average net assets among peers: $1,069,742,905
- Average return on equity (ROE) among peers: -0.76%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Tianshui Zhongxing Bio-technology Co Ltd (002772) | CN¥3.56 Billion | 24.01% | 1.17x | $583.46 Million |
| ShenZhen Kondarl Group Co Ltd (000048) | $82.08 Million | -109.08% | 15.62x | $1.45 Billion |
| Guangdong Guanghong Holdings Co Ltd (000529) | $1.79 Billion | 13.73% | 0.43x | $424.57 Million |
| Hunan Zhenghong Science and Technology Develop Co Ltd (000702) | $575.58 Million | 8.68% | 0.29x | $288.61 Million |
| Hefei Fengle Seed Co Ltd (000713) | $574.87 Million | 11.73% | 1.50x | $741.71 Million |
| Luoniushan Co Ltd (000735) | $3.67 Billion | 4.16% | 0.68x | $950.35 Million |
| New Hope Liuhe Co Ltd (000876) | $1.16 Billion | 7.24% | 0.25x | $4.56 Billion |
| Yuan Longping High-tech Agriculture Co Ltd (000998) | $1.05 Billion | 4.70% | 0.85x | $1.87 Billion |
| Dongrui Food Group Co Ltd (001201) | $160.11 Million | 12.03% | 1.52x | $553.00 Million |
| Jiangxi Sunshine Dairy Co Ltd (001318) | $1.35 Billion | 8.61% | 0.06x | $481.04 Million |
| Shandong Denghai Seeds Co Ltd (002041) | $279.21 Million | 30.58% | 0.68x | $1.28 Billion |
About Tianshui Zhongxing Bio-technology Co Ltd
Tianshui Zhongxing Bio-technology Co.,Ltd., together with its subsidiaries, engages in the research and development, production and sales of edible mushrooms in China and internationally. It offers enoki and button mushrooms; cordyceps militaris; and cordyceps sinensis. The company also engages in agriculture planting, investment management, and real estate development businesses. Tianshui Zhongx… Read more